Carbon Tetrachloride

Carbon Tetrachloride

SCHEMBL5665382

CNC.ClC(Cl)(Cl)Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL4910341 0.87
Dimethylamine SCHEMBL29462048 0.79 KDM4E (0.38)
Carbon Tetrachloride SCHEMBL28079634 0.72
Dimethylamine SCHEMBL28874924 0.72
Dimethylamine SCHEMBL13695986 0.71
Carbon Tetrachloride SCHEMBL3648805 0.71
SCHEMBL3824257 0.71
Dimethylamine SCHEMBL392668 0.71
Dimethylamine SCHEMBL1030 0.71
Dimethylamine SCHEMBL12415750 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113025000-A PEDOT (Poly ethylene terephthalate) PSS (Poly styrene sulfonate) material, processing method and quantum dot light-emitting diode TCL集团股份有限公司 2021-06-25 CN claimed
US-20170240489-A1 SEPARATION PROCESS FOR C8 AROMATICS MIXTURE SULZER MANAGEMENT AG (CH) 2017-08-24 US claimed
JP-8311007-A None JP disclosed
CN-109153674-B Iminothiadiazine dioxide derivatives as inhibitors of plasmepsin V of plasmodium UCB生物制药有限责任公司 2022-03-22 CN disclosed
CN-108290860-B Iminotetrahydropyrimidinone derivatives as PLASMEPSIN V inhibitors UCB生物制药有限责任公司 2021-08-10 CN disclosed
CN-113025000-A PEDOT (Poly ethylene terephthalate) PSS (Poly styrene sulfonate) material, processing method and quantum dot light-emitting diode TCL集团股份有限公司 2021-06-25 CN disclosed
CN-108290860-A Imino group tetrahydropyrimidine ketone derivatives as PLASMEPSIN V inhibitor UCB生物制药私人有限公司 2018-07-17 CN disclosed
US-20070213355-A1 1H-Imidazo[4,5-C]Quinoline Derivatives in the Treatment of Protein Kinase Dependent Diseases CAPRARO HANS-GEORG 2007-09-13 US disclosed
EP-1501826-B1 SUBSTITUTED INDOLES AS ALPHA-1 AGONISTS HOFFMANN LA ROCHE (CH) 2006-09-27 EP disclosed
EP-1689747-A1 1H-IMIDAZO [4,5-C] QUINOLINE DERIVATIVES IN THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES Novartis AG (CH) 2006-08-16 EP disclosed
WO-2005054238-A1 1H-IMIDAZO[4,5-C]QUINOLINE DERIVATIVES IN THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES NOVARTIS AG (CH) 2005-06-16 WO disclosed
US-6852726-B2 Substituted indoles as alpha-1 agonists SYNTEX LLC (US) 2005-02-08 US disclosed
EP-1501826-A2 SUBSTITUTED INDOLES AS ALPHA-1 AGONISTS F. Hoffman-la Roche AG (CH) 2005-02-02 EP disclosed
US-20030220319-A1 Substituted indoles as alpha-1 agonists SYNTEX (U.S.A.) LLC 2003-11-27 US disclosed
WO-2003064387-A2 SUBSTITUTED INDOLES AS ALPHA-1 AGONISTS F. HOFFMAN-LA ROCHE AG (CH) 2003-08-07 WO disclosed
JP-H08311007-A AZULENE-1-CARBOXAMIDINE DERIVATIVE TAISHO PHARMACEUT CO LTD 1996-11-26 JP disclosed
US-4313931-A ANTIHISTAMINES, ANTISEROTONINE AGENTS, ANTIALLERGENS, BRONCHODILATOR AGENTS, ANTIANAPHYLACTIC AGENTS BOEHRINGER INGELHEIM KG (DE) 1982-02-02 US disclosed